← Eichor
Condition: Metastatic Malignant Neoplasm In The Central Nervous System Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Metastatic Malignant Neoplasm In The Central Nervous System

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
Phase 2 · 1 location(s) · TYK Medicines, Inc · NCT05948813Neurocutaneous Melanocytosis Registry
Phase N/A · 2 location(s) · Memorial Sloan Kettering Cancer Center · NCT04548817Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Phase 3 · 4 location(s) · Mayo Clinic · NCT03750227Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NA · 2 location(s) · Brigham and Women's Hospital · NCT04033497ioMRI in the Surgery of Brain Metastases.
NA · 1 location(s) · Technical University of Munich · NCT07197632RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastati
Phase 2/Phase 3 · 109 location(s) · Hoffmann-La Roche · NCT07413939Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT07100600A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatmen
Phase 2 · 1 location(s) · Shanghai Cancer Hospital, China · NCT06901817Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
Phase 4 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07092202Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07339085A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants Wit
Phase 3 · 281 location(s) · Celgene · NCT06764485SBRT in the Management of Solid Spinal Metastases
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04863612Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Phase 2 · 1 location(s) · Sheba Medical Center · NCT05909618Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT03741673A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC
Phase 1/Phase 2 · 1 location(s) · Wayshine Biopharm, Inc. · NCT07206498Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
Phase 1/Phase 2 · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT04923542Frameless Stereotactic Radiosurgery for Intact Brain Metastases
Phase 2 · 1 location(s) · University of Chicago · NCT02747303Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
Phase 2 · 1 location(s) · OHSU Knight Cancer Institute · NCT03270059Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02754544Non-small Cell Lung Cancer With Central Nervous System Metastasis
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06026735Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to
Phase 3 · 270 location(s) · NRG Oncology · NCT06500455An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastas
Phase 4 · 1 location(s) · City of Hope Medical Center · NCT05376878Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat
Phase 4 · 1 location(s) · Maastricht University Medical Center · NCT05748093Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative B
Phase 2 · 3 location(s) · Roswell Park Cancer Institute · NCT04348747Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
EARLY_Phase 1 · 1 location(s) · Emory University · NCT06328686Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Phase 1 · 5 location(s) · Alpha Biopharma (Jiangsu) Co., Ltd. · NCT07361705Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT04988009Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT06910761Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases
NA · 1 location(s) · Regina Elena Cancer Institute · NCT06992973
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.